ArticleCureus2025
Amoxicillin-Triggered Rash in Latent Epstein-Barr Virus Infection: A Case of Kawasaki Disease Mimicry in a Seven-Year-Old Girl.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amoxicillin-associated rash is a well-documented phenomenon in Epstein-Barr virus (EBV)-related infectious mononucleosis. This case highlights a notable course where amoxicillin was administered during the latent phase of EBV infection, and the characteristic rash appeared following the clinical onset of infectious mononucleosis. A seven-year-old girl received amoxicillin for acute otitis media during EBV's latent phase. After developing fever, conjunctival injection, lip redness, cervical lymphadenopathy, and a generalized rash, she was initially diagnosed with Kawasaki disease and treated with intravenous immunoglobulin and aspirin. Serological testing later confirmed acute EBV infection, and the rash was attributed to prior amoxicillin use. This case illustrates that aminopenicillins, such as amoxicillin, can trigger characteristic rashes after the onset of infectious mononucleosis, even when administered during the infection's latent phase. It highlights the importance of detailed medication history-taking, particularly regarding drug use during the latent period, and the consideration of viral etiologies in febrile illnesses with rash, especially when symptoms overlap with systemic inflammatory conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.